The Probiotic Lactobacillus Prevents Citrobacter rodentium-Induced Murine Colitis in a TLR2-Dependent Manner
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The main objective of this study was to investigate whether Lactobacillus rhamnosus GG (LGG) ameliorated the effects of Citrobactor rodentium infection in Toll-like receptor 2 (TLR2) knockout (KO) and TLR4 KO mice, as well as in wild-type C57BL/6 (B6) mice. TLR2 KO, TLR4 KO, and B6 mice were divided into three groups per each strain. Each group had an uninfected control group (n = 5), C. rodentium-infected group (n = 8), and LGG-pretreated C. rodentium-infected group (n = 8). The survival rate of B6 mice infected with C. rodentium was higher when pretreated with LGG. Pretreatment with LGG ameliorated C. rodentiuminduced mucosal hyperplasia in B6 and TLR4 KO mice. However, in C-rodentium-infected TLR2 KO mice, mucosal hyperplasia persisted, regardless of pretreatment with LGG. In addition, LGG-pretreated B6 and TLR4 KO mice showed a decrease in spleen weight and downregulation of tumor necrosis factor alpha, interferon gamma, and monocyte chemotactic protein 1 mRNA expression compared with the non-pretreated group. In contrast, such changes were not observed in TLR2 KO mice, regardless of pretreatment with LGG. From the above results, we conclude that pretreatment with LGG ameliorates C. rodentium-induced colitis in B6 and TLR4 KO mice, but not in TLR2 KO mice. Therefore, LGG protects mice from C. rodentium-induced colitis in a TLR2-dependent manner.
Abstract
The main objective of this study was to investigate whether Lactobacillus rhamnosus GG (LGG) ameliorated the effects of Citrobactor rodentium infection in Toll-like receptor 2 (TLR2) knockout (KO) and TLR4 KO mice, as well as in wild-type C57BL/6 (B6) mice. TLR2 KO, TLR4 KO, and B6 mice were divided into three groups per each strain. Each group had an uninfected control group (n = 5), C. rodentium-infected group (n = 8), and LGG-pretreated C. rodentium-infected group (n = 8). The survival rate of B6 mice infected with C. rodentium was higher when pretreated with LGG. Pretreatment with LGG ameliorated C. rodentiuminduced mucosal hyperplasia in B6 and TLR4 KO mice. However, in C-rodentium-infected TLR2 KO mice, mucosal hyperplasia persisted, regardless of pretreatment with LGG. In addition, LGG-pretreated B6 and TLR4 KO mice showed a decrease in spleen weight and downregulation of tumor necrosis factor alpha, interferon gamma, and monocyte chemotactic protein 1 mRNA expression compared with the non-pretreated group. In contrast, such changes were not observed in TLR2 KO mice, regardless of pretreatment with LGG. From the above results, we conclude that pretreatment with LGG ameliorates C. rodentium-induced colitis in B6 and TLR4 KO mice, but not in TLR2 KO mice. Therefore, LGG protects mice from C. rodentium-induced colitis in a TLR2-dependent manner.
참고문헌 (36)
- Barthold SW, "Transmissible murine colonic hyperplasia", Vet. Pathol, 15, pp.223~236 (1978)
- Ciorba MA, "Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2", cyclo-oxygenase-2-dependent manner, 2012, pp.61, 829~838
- Dalton DK, "Multiple defects of immune cell function in mice with disrupted interferon-gamma genes", Science, 259, pp.1739~1742 (1993)
- Deng W, "Locus of enterocyte effacement from Citrobacter rodentium: sequence analysis and evidence for horizontal transfer among attaching and effacing pathogens", Infect. Immun, 69, pp.6323~6335 (2001)
- Dogi CA, "Gut immune stimulation by non pathogenic gram (+) and gram (−)bacteria. Comparison with a probiotic strain", Cytokine, 41, pp.223~231 (2008)
- Dong L, "Toll-like receptor 2monoclonal antibody or", and Toll-like receptor 4 monoclonal antibody increase counts of lactobacilli and bifidobacteria in dextran sulfate sodium-induced colitis in mice, 2012, pp.27, 110~119
- Dorner BG, "MIP-1α, MIP-1β, RANTES, and ATAC", lymphotactin function together with IFN-γ as type 1cytokines, 2002, pp.99, 6181~6186
- Doron S, "Lactobacillus GG:bacteriology and clinical applications", Gastroenterol. Clin. North Am, 34, pp.483~498 (2005)
- Gibson DL, "Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis", Cell. Microbiol, 10, pp.388~403 (2008)
- Hartland EL, "Binding of intimin from enteropathogenic Escherichia coli to Tir and to host cells", Mol. Microbiol, 32, pp.151~158 (1999)
- Higgins LM, "Role of bacterial intimin in colonic hyperplasia and inflammation", Science, 285, pp.588~591 (1999)
- Higgins LM, "Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease", Infect. Immun, 67, pp.3031~3039 (1996)
- Johansson ML, "Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats", Int. J. Food Microbiol, 42, pp.29~38 (1998)
- Johnson-Henry KC, "Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics", J. Infect. Dis, 191, pp.2106~2117 (2005)
- Kerr AR, "Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection", Infect. Immun, 70, pp.1547~1557 (2002)
- Khan MA, "Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice", Infect. Immun, 74, pp.2522~2536 (2006)
- Kim M, "Bacterial interactions with the host epithelium", Cell Host Microbe, 8, pp.20~35 (2010)
- Kruis W, "Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine", Gut, 53, pp.1617~1623 (2004)
- Luperchio SA, "Citrobacter rodentium, the causative agent of transmissible murine colonic hyperplasia, exhibits clonality: synonymy of C. rodentium and mouse-pathogenic Escherichia coli", J. Clin. Microbiol, 38, pp.4343~4350 (2000)
- Luperchio SA, "Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia", Microbes Infect, 3, pp.333~340 (2001)
- Moayyedi P, "The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review", Gut, 59, pp.325~332 (2010)
- Mukai T, "Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri", FEMS Immunol. Med. Microbiol, 32, pp.105~110 (2002)
- Mundy R, "Citrobacter rodentium of mice and man", Cell. Microbiol, 7, pp.1697~1706 (2005)
- Nataro JP, "Diarrheagenic Escherichia coli", Clin. Microbiol. Rev, 11, pp.142~201 (1998)
- Rakoff-Nahoum S, "Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis", Cell, 118, pp.229~241 (2004)
- Rath HC, "Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27", human beta2 microglobulin transgenic rats, 1996, pp.98, 945~953
- Rodrigues DM, "Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice", J. Infect. Dis, 206, pp.99~109 (2012)
- Sartor RB, "Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis", Nat. Clin. Pract. Gastroenterol. Hepatol, 3, pp.390~407 (2006)
- Sartor RB, "Microbial influences in inflammatory bowel diseases", Gastroenterology, 134, pp.577~594 (2008)
- Schauer DB, "Genetic and biochemical characterization of Citrobacter rodentium sp. nov", J. Clin. Microbiol, 33, pp.2064~2068 (1995)
- Takeda K, "Toll-like receptors in innate immunity", Int. Immunol, 17, pp.1~14 (2005)
- Wei OL, "Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium", Infect. Immun, 73, pp.1978~1985 (2005)
- Williams MD, "Probiotics as therapy in gastroenterology: a study of physician opinions and recommendations", J. Clin. Gastroenterol, 44, pp.631~636 (2010)
- Williams NT, "Probiotics", Am. J. Health Syst. Pharm, 67, pp.449~458 (2010)
- Xu LL, "Human recombinant monocyte chemotactic protein and other CC chemokines bind and induce directional migration of dendritic cells in vitro", J. Leukoc. Biol, 60, pp.365~371 (1996)
- Yan F, "Lactobacillus rhamnosus GG: an updated strategy to use microbial products to promote health", Funct. Food Rev, 4, pp.77~84 (2012)